Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fort Lauderdale, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Alaunos Therapeutics, Inc. has filed 1,290 SEC EDGAR filings since 13 Feb 2001

SEC filing history

Showing 651-675 of 1,000 matching filings.

Per page
25
Current page
27
4

FORM 4 SUBMISSION

Filing date
23 Nov 2015
Reporting date
19 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
19 Nov 2015
Reporting date
19 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
12 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

8-K

Filing date
02 Nov 2015
Reporting date
02 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
01 Oct 2015
Reporting date
28 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Sep 2015
Reporting date
25 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
29 Sep 2015
Reporting date
25 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
28 Sep 2015
Reporting date
28 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
28 Sep 2015
Reporting date
25 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
10 Sep 2015
Reporting date
10 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
21 Aug 2015
Reporting date
17 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
10 Aug 2015
Reporting date
10 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
19 Jun 2015
Reporting date
17 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
18 Jun 2015
Reporting date
18 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-33038

CT ORDER filing

Filing date
12 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Jun 2015
Reporting date
09 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79364

RANDAL J KIRK SC 13DA NO7 6-4-2015 (ZIOPHARM ONCOLOGY INC)

Filing date
09 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
08 Jun 2015
Reporting date
04 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-33038

AMENDMENT NO. 1 FOR FORM 8-K

Filing date
08 Jun 2015
Reporting date
27 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jun 2015
Reporting date
03 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jun 2015
Reporting date
03 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jun 2015
Reporting date
01 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
02 Jun 2015
Reporting date
01 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .